TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
2016 ◽
Vol 17
(2)
◽
pp. 212-223
◽
Keyword(s):
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7141-7141
Keyword(s):
2003 ◽
Vol 29
(2)
◽
pp. 127-129
◽
Keyword(s):
2020 ◽
Vol 12
◽
pp. 175883592098036
2013 ◽
Vol 8
(10)
◽
pp. 1255-1264
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 15
(8)
◽
pp. 669-682
◽
Keyword(s):